ATE549313T1 - Verbindungen mit antitumorwirkung - Google Patents
Verbindungen mit antitumorwirkungInfo
- Publication number
- ATE549313T1 ATE549313T1 AT08865009T AT08865009T ATE549313T1 AT E549313 T1 ATE549313 T1 AT E549313T1 AT 08865009 T AT08865009 T AT 08865009T AT 08865009 T AT08865009 T AT 08865009T AT E549313 T1 ATE549313 T1 AT E549313T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- antitumor effects
- antitumor
- cancer
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07123882 | 2007-12-20 | ||
PCT/EP2008/068065 WO2009080769A1 (en) | 2007-12-20 | 2008-12-19 | Antitumoral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE549313T1 true ATE549313T1 (de) | 2012-03-15 |
Family
ID=40580474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08865009T ATE549313T1 (de) | 2007-12-20 | 2008-12-19 | Verbindungen mit antitumorwirkung |
Country Status (27)
Country | Link |
---|---|
US (4) | US9187445B2 (de) |
EP (3) | EP2231633B1 (de) |
JP (3) | JP5529038B2 (de) |
KR (3) | KR101579553B1 (de) |
CN (4) | CN101903367B (de) |
AT (1) | ATE549313T1 (de) |
AU (2) | AU2008341670B2 (de) |
BR (2) | BRPI0821114B8 (de) |
CA (2) | CA2710087C (de) |
CY (1) | CY1117245T1 (de) |
DK (2) | DK2231590T3 (de) |
ES (3) | ES2442140T3 (de) |
HK (3) | HK1147990A1 (de) |
HR (2) | HRP20120464T1 (de) |
IL (3) | IL206396A (de) |
MX (2) | MX2010006796A (de) |
MY (3) | MY164533A (de) |
NZ (3) | NZ586012A (de) |
PL (2) | PL2231633T3 (de) |
PT (2) | PT2231590E (de) |
RS (2) | RS52343B (de) |
RU (3) | RU2489429C2 (de) |
SG (2) | SG170778A1 (de) |
SI (2) | SI2231590T1 (de) |
UA (3) | UA106967C2 (de) |
WO (2) | WO2009080761A1 (de) |
ZA (3) | ZA201004017B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101903367B (zh) | 2007-12-20 | 2015-08-05 | 法马马有限公司 | 抗肿瘤化合物 |
CN104039315B (zh) * | 2012-01-05 | 2016-08-24 | 花王株式会社 | 用于降低感觉刺激的制剂 |
AU2014255326B2 (en) | 2013-04-16 | 2018-09-13 | Idorsia Pharmaceuticals Ltd | Antibacterial biaromatic derivatives |
GB201309807D0 (en) * | 2013-05-31 | 2013-07-17 | Pharma Mar Sau | Antibody drug conjugates |
CN108467378A (zh) * | 2017-02-23 | 2018-08-31 | 复旦大学 | 一种二氢吡喃酮类化合物及其制备方法和用途 |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4855086A (en) * | 1982-10-15 | 1989-08-08 | Burroughs Wellcome Co. | Novel pesticides, preparation and use |
JPS61109717A (ja) | 1984-11-02 | 1986-05-28 | Teruhiko Beppu | 抗腫瘍剤 |
CA2098702A1 (en) * | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
JPH0539283A (ja) | 1991-01-31 | 1993-02-19 | Suntory Ltd | 新規物質S−59917a及びその製造方法 |
ZA938019B (en) | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
US5523456A (en) * | 1994-09-29 | 1996-06-04 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5681847A (en) * | 1995-12-05 | 1997-10-28 | Harbor Branch Oceanographic Institution, Inc. | Methods of using discodermolide compounds |
US5834506A (en) | 1996-11-01 | 1998-11-10 | Warner-Lambert Company | Dihydropyrones with improved antiviral activity |
US5840974A (en) * | 1996-12-04 | 1998-11-24 | Britisch Biotech Pharmaceuticals, Ltd. | Metalloproteinase inhibitors |
US6380400B1 (en) | 1998-09-11 | 2002-04-30 | Victor Fedij | Methods of making dihydropyrone HIV protease inhibitors |
BR9913598A (pt) | 1998-09-11 | 2001-05-29 | Warner Lambert Co | Inibidores de protease de hiv |
WO2001074355A1 (en) * | 2000-04-04 | 2001-10-11 | Novartis Ag | Method for treating cells resistant to antineoplastic agents |
NZ567758A (en) * | 2002-03-04 | 2009-07-31 | Merck Hdac Res Llc | Methods of inducing terminal differentiation using suberoylanilide hydrozmic acid (SAHA) |
CN1856486A (zh) * | 2003-07-25 | 2006-11-01 | 诺瓦提斯公司 | 取代的内酰胺和它们作为抗癌剂的用途 |
RU2006142690A (ru) * | 2004-06-03 | 2008-06-10 | Козан Байосайенсиз Инкорпорейтед (Us) | Соединения лептомицина |
US7446196B2 (en) | 2004-06-03 | 2008-11-04 | Kosan Biosciences, Incorporated | Leptomycin compounds |
WO2007014423A1 (en) * | 2005-08-02 | 2007-02-08 | Medvet Science Pty, Ltd. | Exercise apparatus |
EP2032551B9 (de) * | 2006-06-16 | 2012-02-29 | Pharma Mar, S.A. | Dihydropyran-2-onverbindungen mit antitumorwirkung |
CN101903367B (zh) | 2007-12-20 | 2015-08-05 | 法马马有限公司 | 抗肿瘤化合物 |
-
2008
- 2008-12-19 CN CN200880121840.6A patent/CN101903367B/zh active Active
- 2008-12-19 CN CN2011100568656A patent/CN102174058A/zh active Pending
- 2008-12-19 AT AT08865009T patent/ATE549313T1/de active
- 2008-12-19 NZ NZ586012A patent/NZ586012A/en unknown
- 2008-12-19 DK DK08865009.8T patent/DK2231590T3/da active
- 2008-12-19 CN CN2008801218410A patent/CN101903337B/zh active Active
- 2008-12-19 PT PT08865009T patent/PT2231590E/pt unknown
- 2008-12-19 MX MX2010006796A patent/MX2010006796A/es active IP Right Grant
- 2008-12-19 SG SG201102163-1A patent/SG170778A1/en unknown
- 2008-12-19 CN CN201110073931.0A patent/CN102190643B/zh active Active
- 2008-12-19 PT PT88648951T patent/PT2231633E/pt unknown
- 2008-12-19 ES ES08864895.1T patent/ES2442140T3/es active Active
- 2008-12-19 NZ NZ597526A patent/NZ597526A/en unknown
- 2008-12-19 UA UAA201009034A patent/UA106967C2/uk unknown
- 2008-12-19 NZ NZ586013A patent/NZ586013A/en unknown
- 2008-12-19 RU RU2010130253/04A patent/RU2489429C2/ru active
- 2008-12-19 DK DK08864895.1T patent/DK2231633T3/da active
- 2008-12-19 WO PCT/EP2008/068049 patent/WO2009080761A1/en active Application Filing
- 2008-12-19 KR KR1020107015968A patent/KR101579553B1/ko active IP Right Grant
- 2008-12-19 RS RS20120242A patent/RS52343B/en unknown
- 2008-12-19 MY MYPI2014002392A patent/MY164533A/en unknown
- 2008-12-19 PL PL08864895T patent/PL2231633T3/pl unknown
- 2008-12-19 ES ES08865009T patent/ES2384420T3/es active Active
- 2008-12-19 BR BRPI0821114A patent/BRPI0821114B8/pt active IP Right Grant
- 2008-12-19 JP JP2010538765A patent/JP5529038B2/ja active Active
- 2008-12-19 RU RU2010130180/04A patent/RU2493147C2/ru active
- 2008-12-19 ES ES13154647.5T patent/ES2578606T3/es active Active
- 2008-12-19 MY MYPI2010002590A patent/MY148651A/en unknown
- 2008-12-19 CA CA2710087A patent/CA2710087C/en active Active
- 2008-12-19 CA CA2715203A patent/CA2715203C/en active Active
- 2008-12-19 KR KR1020107015965A patent/KR101541436B1/ko active IP Right Grant
- 2008-12-19 EP EP08864895.1A patent/EP2231633B1/de active Active
- 2008-12-19 PL PL08865009T patent/PL2231590T3/pl unknown
- 2008-12-19 RS RS20140007A patent/RS53140B/en unknown
- 2008-12-19 AU AU2008341670A patent/AU2008341670B2/en active Active
- 2008-12-19 AU AU2008341671A patent/AU2008341671B2/en active Active
- 2008-12-19 US US12/746,974 patent/US9187445B2/en active Active
- 2008-12-19 SI SI200830644T patent/SI2231590T1/sl unknown
- 2008-12-19 UA UAA201406894A patent/UA119963C2/uk unknown
- 2008-12-19 EP EP13154647.5A patent/EP2597091B1/de active Active
- 2008-12-19 EP EP08865009A patent/EP2231590B9/de active Active
- 2008-12-19 MY MYPI2010002591A patent/MY155342A/en unknown
- 2008-12-19 KR KR1020157016575A patent/KR101639772B1/ko active IP Right Grant
- 2008-12-19 WO PCT/EP2008/068065 patent/WO2009080769A1/en active Application Filing
- 2008-12-19 MX MX2010006795A patent/MX2010006795A/es active IP Right Grant
- 2008-12-19 SI SI200831122T patent/SI2231633T1/sl unknown
- 2008-12-19 BR BRPI0821116A patent/BRPI0821116B8/pt active IP Right Grant
- 2008-12-19 JP JP2010538769A patent/JP5727228B2/ja active Active
- 2008-12-19 UA UAA201009035A patent/UA104281C2/ru unknown
- 2008-12-19 SG SG201102164-9A patent/SG170779A1/en unknown
- 2008-12-19 RU RU2013112003/04A patent/RU2528393C9/ru active
- 2008-12-19 US US12/746,966 patent/US8710264B2/en active Active
-
2010
- 2010-06-04 ZA ZA2010/04017A patent/ZA201004017B/en unknown
- 2010-06-04 ZA ZA2010/04018A patent/ZA201004018B/en unknown
- 2010-06-15 IL IL206396A patent/IL206396A/en active IP Right Grant
- 2010-06-15 IL IL206397A patent/IL206397A/en active IP Right Grant
-
2011
- 2011-03-01 HK HK11102050.0A patent/HK1147990A1/xx unknown
- 2011-03-01 HK HK11102052.8A patent/HK1147998A1/xx unknown
- 2011-03-01 HK HK13107821.5A patent/HK1180678A1/zh unknown
- 2011-08-31 ZA ZA2011/06371A patent/ZA201106371B/en unknown
-
2012
- 2012-06-01 HR HRP20120464AT patent/HRP20120464T1/hr unknown
-
2013
- 2013-11-24 IL IL229594A patent/IL229594A/en active IP Right Grant
-
2014
- 2014-01-08 HR HRP20140015AT patent/HRP20140015T1/hr unknown
- 2014-01-27 CY CY20141100069T patent/CY1117245T1/el unknown
- 2014-04-10 JP JP2014080887A patent/JP5860088B2/ja active Active
-
2015
- 2015-08-12 US US14/824,699 patent/US9827257B2/en active Active
- 2015-08-12 US US14/824,690 patent/US9750759B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
GEP20125702B (en) | Benzimidazole derivatives | |
MX2010002243A (es) | Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida. | |
BRPI0607379B8 (pt) | composição farmacêutica de efeito analgésico | |
TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
MY150493A (en) | Quinazoline derivatives | |
ATE549313T1 (de) | Verbindungen mit antitumorwirkung | |
MY159479A (en) | Herbicides | |
ATE476973T1 (de) | Verbindungen mit antitumorwirkung | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
TW200626588A (en) | (Arylamidoaryl)cyanoguanidine compounds | |
WO2010149688A3 (en) | Antitumoral compounds | |
NZ593169A (en) | Anticancer compounds | |
GB0620005D0 (en) | Compounds | |
ATE547414T1 (de) | 4-oxadiazolylpiperidinverbindungen und deren verwendung |